Zobrazeno 1 - 10
of 59
pro vyhledávání: '"FS Rodrigues"'
Autor:
FS Rodrigues, MLM Martins, GLS Cordeiro, VC Monici, CCB Silva, MDS Montenegro, SMCBP Jesus, MMAS Arruda
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp S270- (2024)
Introdução: O Linfoma de Células T/NK é um subtipo raro e agressivo de Linfoma não-Hodgkin que acomete principalmente populações asiáticas e latino-americanas. Comumente afeta regiões extranodais, em especial a cavidade nasal, e pode ser cau
Externí odkaz:
https://doaj.org/article/aa29b3b8bd434108928af27592bf6797
Autor:
RMS Soares, DN Cysne, CC Sartório, VL Brandão, D Escorcio, EA Bruno, FS Rodrigues, GTM Morais, TR Souto, FD Xavier
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp S275- (2024)
Introdução: Os Linfomas não-Hodgkin (LNH) são malignidades heterogêneas do tecido linfoide, derivados de linfócitos B e T ou células natural killer (NK). O linfoma difuso de grandes células B (LDGCB) é o subtipo histológico mais prevalente,
Externí odkaz:
https://doaj.org/article/d340e9e3088f47d7bd1bfaaca1b5c3d2
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp S596- (2024)
Objetivo: A Síndrome do Anticorpo Antifosfolipídeo (SAF) é uma condição autoimune caracterizada pela produção de auto-anticorpos do tipo antifosfolipídicos (aPL) no sangue. Estes anticorpos interferem na coagulação sanguínea normal, aument
Externí odkaz:
https://doaj.org/article/93a0c05776004e8b91c96e2c3fd734ff
Autor:
IDM Gonçalves, PHM Pereira, AS Fujita, JVM Cunha, FS Rodrigues, GTM Morais, MCS Freitas, MDS Montenegro
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S969-S970 (2023)
Objetivos: Relatar e descrever estratégias de organização e impactos envolvidos na realização de um evento acadêmico por uma liga acadêmica de Hematologia. Material e métodos: Realizado pela Liga Acadêmica de Hematologia da UnB (LAHem) no di
Externí odkaz:
https://doaj.org/article/b41ae392879e4d35b7712376160fb06b
Autor:
Rodrigues FS; Champalimaud Foundation, Champalimaud Neuroscience Program, Lisbon, Portugal. Electronic address: filipe.rodrigues@neuro.fchampalimaud.org., Monteiro T; Konrad Lorenz Institute of Ethology, Department of Interdisciplinary Life Sciences, Vienna, Austria; University of Aveiro, William James Center for Research, Aveiro, Portugal; University of Aveiro, Department of Education and Psychology, Aveiro, Portugal., Motiwala A; Carnegie Mellon University, Department of Electrical and Computer Engineering, Pittsburgh, Pennsylvania, USA., Paton JJ; Champalimaud Foundation, Champalimaud Neuroscience Program, Lisbon, Portugal. Electronic address: joe.paton@neuro.fchampalimaud.org.
Publikováno v:
Neuron [Neuron] 2024 Nov 20; Vol. 112 (22), pp. 3675-3677.
Autor:
Rodrigues FS; Tumour-Host Interaction Laboratory, The Francis Crick Institute, London, UK., Karoutas A; Tumour-Host Interaction Laboratory, The Francis Crick Institute, London, UK., Ruhland S; Tumour-Host Interaction Laboratory, The Francis Crick Institute, London, UK., Rabas N; Tumour-Host Interaction Laboratory, The Francis Crick Institute, London, UK., Rizou T; Tumour-Host Interaction Laboratory, The Francis Crick Institute, London, UK., Di Blasio S; Tumour-Host Interaction Laboratory, The Francis Crick Institute, London, UK., Ferreira RMM; Tumour-Host Interaction Laboratory, The Francis Crick Institute, London, UK., Bridgeman VL; Tumour-Host Interaction Laboratory, The Francis Crick Institute, London, UK., Goldstone R; Bioinformatics & Biostatistics Unit, The Francis Crick Institute, London, UK., Sopena ML; Bioinformatics & Biostatistics Unit, The Francis Crick Institute, London, UK., Lee JH; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK., Ombrato L; Barts Cancer Institute, Queen Mary University of London, London, UK., Malanchi I; Tumour-Host Interaction Laboratory, The Francis Crick Institute, London, UK. Electronic address: ilaria.malanchi@crick.ac.uk.
Publikováno v:
Developmental cell [Dev Cell] 2024 Sep 23; Vol. 59 (18), pp. 2398-2413.e8. Date of Electronic Publication: 2024 Jun 11.
Autor:
Godoy TA; Laboratório de Herpetologia, Instituto Butantan, São Paulo, Brazil.; Programa de Pós-Graduação Interunidades em Biotecnologia, São Paulo, Brazil.; Escola Superior do Instituto Butantan, São Paulo, Brazil., Lima EOV; Laboratório de Herpetologia, Instituto Butantan, São Paulo, Brazil.; Programa de Pós-Graduação Interunidades em Biotecnologia, São Paulo, Brazil., Silveira GPM; Laboratório de Herpetologia, Instituto Butantan, São Paulo, Brazil., Rodrigues FS; Laboratório de Herpetologia, Instituto Butantan, São Paulo, Brazil., Sant'anna SS; Laboratório de Herpetologia, Instituto Butantan, São Paulo, Brazil., Hatakeyama DM; Departamento de Bioquímica, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil., Grego KF; Laboratório de Herpetologia, Instituto Butantan, São Paulo, Brazil., Tanaka-Azevedo AM; Laboratório de Herpetologia, Instituto Butantan, São Paulo, Brazil.; Programa de Pós-Graduação Interunidades em Biotecnologia, São Paulo, Brazil.; Escola Superior do Instituto Butantan, São Paulo, Brazil.
Publikováno v:
Heliyon [Heliyon] 2024 Aug 30; Vol. 10 (17), pp. e37262. Date of Electronic Publication: 2024 Aug 30 (Print Publication: 2024).
Autor:
Rodrigues FS; Laboratório de Síntese Inorgânica e Bioinorgânica, Instituto de Química, Universidade de Brasília, Brasília, DF, Brazil., da Silva VAM; Laboratório de Síntese Inorgânica e Bioinorgânica, Instituto de Química, Universidade de Brasília, Brasília, DF, Brazil., Segovia GBQ; Laboratório de Síntese Inorgânica e Bioinorgânica, Instituto de Química, Universidade de Brasília, Brasília, DF, Brazil., Bortoluzzi AJ; Laboratório de Bioinorgânica e Cristalografia (LABINC), Departamento de Química, Universidade de Santa Catarina, Florianópolis, SC, Brazil., Cuin A; Laboratório de Quimica Bioinorgânica, Departamento de Química, Instituto de Ciências Exatas, Universidade Federal de Juiz de Fora, Juiz de Fora, MG, Brazil., de Souza JIR; Programa de Pós-Graduação em Ciência de Materiais, Universidade Federal de Pernambuco, Recife, PE, Brazil., da Silva JAB; Núcleo Interdisciplinar de Ciências Exatas e da Natureza, Campus do Agreste, Universidade Federal de Pernambuco, Caruaru, PE, Brazil; Programa de Pós-Graduação em Química, Universidade Federal Rural de Pernambuco, Recife, PE, Brazil., Lourenço da Luz L; Departamento de Química Fundamental, Universidade Federal de Pernambuco, Recife, PE, Brazil., Alves Júnior S; Departamento de Química Fundamental, Universidade Federal de Pernambuco, Recife, PE, Brazil., Tonon de Almeida E; Instituto de Química, Universidade Federal de Alfenas, Alfenas, MG, Brazil., Camargo MA; Laboratório de Síntese Inorgânica e Bioinorgânica, Instituto de Química, Universidade de Brasília, Brasília, DF, Brazil. Electronic address: maryene@unb.br.
Publikováno v:
Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy [Spectrochim Acta A Mol Biomol Spectrosc] 2023 Aug 05; Vol. 296, pp. 122677. Date of Electronic Publication: 2023 Mar 31.
Autor:
Monteiro T; Neuroscience Programme, Champalimaud Foundation, Lisbon, Portugal.; Department of Biology, University of Oxford, Oxford, UK., Rodrigues FS; Neuroscience Programme, Champalimaud Foundation, Lisbon, Portugal., Pexirra M; Neuroscience Programme, Champalimaud Foundation, Lisbon, Portugal.; Sainsbury Wellcome Centre for Neural Circuits and Behaviour, University College London, London, UK., Cruz BF; Neuroscience Programme, Champalimaud Foundation, Lisbon, Portugal.; NeuroGEARS Ltd., London, UK., Gonçalves AI; Neuroscience Programme, Champalimaud Foundation, Lisbon, Portugal., Rueda-Orozco PE; Institute of Neurobiology, UNAM Juriquilla, Juriquilla, Mexico., Paton JJ; Neuroscience Programme, Champalimaud Foundation, Lisbon, Portugal. joe.paton@neuro.fchampalimaud.org.
Publikováno v:
Nature neuroscience [Nat Neurosci] 2023 Aug; Vol. 26 (8), pp. 1407-1416. Date of Electronic Publication: 2023 Jul 13.
Autor:
Hill W; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Lim EL; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Weeden CE; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Lee C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Division of Medicine, University College London, London, UK., Augustine M; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Division of Medicine, University College London, London, UK.; Tumour Immunogenomics and Immunosurveillance Laboratory, University College London Cancer Institute, London, UK., Chen K; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Department of Thoracic Surgery and Thoracic Oncology Institute, Peking University People's Hospital, Beijing, China., Kuan FC; Department of Hematology and Oncology, Chang Gung Memorial Hospital, Chiayi Branch, Chiayi, Taiwan.; Graduate Institute of Clinical Medical Sciences, Chang-Gung University, Taoyuan, Taiwan., Marongiu F; Department of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.; Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy., Evans EJ Jr; Department of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Moore DA; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Department of Cellular Pathology, University College London Hospitals, London, UK., Rodrigues FS; Tumour-Host Interaction Laboratory, The Francis Crick Institute, London, UK., Pich O; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Bakker B; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Cha H; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Myers R; BC Cancer Research Institute, University of British Columbia, Vancouver, British Columbia, Canada., van Maldegem F; Oncogene Biology Laboratory, The Francis Crick Institute, London, UK.; Department of Molecular Cell Biology and Immunology, Amsterdam UMC, Amsterdam, The Netherlands., Boumelha J; Oncogene Biology Laboratory, The Francis Crick Institute, London, UK., Veeriah S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Rowan A; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Naceur-Lombardelli C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Karasaki T; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK., Sivakumar M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., De S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Caswell DR; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Nagano A; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Black JRM; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Martínez-Ruiz C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Ryu MH; Department of Medicine, Division of Respiratory Medicine, Chan-Yeung Centre for Occupational and Environmental Respiratory Disease, Vancouver Coastal Health Research Institute, UBC, Vancouver, British Columbia, Canada., Huff RD; Department of Medicine, Division of Respiratory Medicine, Chan-Yeung Centre for Occupational and Environmental Respiratory Disease, Vancouver Coastal Health Research Institute, UBC, Vancouver, British Columbia, Canada., Li S; Department of Medicine, Division of Respiratory Medicine, Chan-Yeung Centre for Occupational and Environmental Respiratory Disease, Vancouver Coastal Health Research Institute, UBC, Vancouver, British Columbia, Canada., Favé MJ; Ontario Institute for Cancer Research, Toronto, Ontario, Canada., Magness A; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Suárez-Bonnet A; Department of Pathobiology and Population Sciences, The Royal Veterinary College, Hatfield, UK.; Experimental Histopathology, The Francis Crick Institute, London, UK., Priestnall SL; Department of Pathobiology and Population Sciences, The Royal Veterinary College, Hatfield, UK.; Experimental Histopathology, The Francis Crick Institute, London, UK., Lüchtenborg M; National Disease Registration Service (NDRS), NHS England, Leeds, UK.; Centre for Cancer, Society and Public Health, Comprehensive Cancer Centre, School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Lavelle K; National Disease Registration Service (NDRS), NHS England, Leeds, UK., Pethick J; National Disease Registration Service (NDRS), NHS England, Leeds, UK., Hardy S; National Disease Registration Service (NDRS), NHS England, Leeds, UK., McRonald FE; National Disease Registration Service (NDRS), NHS England, Leeds, UK., Lin MH; Health Information and Epidemiology Laboratory, Chang-Gung Memorial Hospital, Chiayi, Taiwan., Troccoli CI; Department of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.; Flagship Biosciences, Boulder, CO, USA., Ghosh M; Division of Pulmonary Sciences and Critical Care Medicine, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Miller YE; Division of Pulmonary Sciences and Critical Care Medicine, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.; Veterans Affairs Eastern Colorado Healthcare System, Aurora, CO, USA., Merrick DT; Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Keith RL; Division of Pulmonary Sciences and Critical Care Medicine, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.; Veterans Affairs Eastern Colorado Healthcare System, Aurora, CO, USA., Al Bakir M; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Bailey C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Hill MS; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Saal LH; SAGA Diagnostics, Lund, Sweden.; Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden., Chen Y; SAGA Diagnostics, Lund, Sweden.; Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden., George AM; SAGA Diagnostics, Lund, Sweden.; Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden., Abbosh C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Kanu N; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Lee SH; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., McGranahan N; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Berg CD; Early Cancer Detection Consultant, Bethesda, MD, USA., Sasieni P; Comprehensive Cancer Centre, King's College London, London, UK., Houlston R; Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK., Turnbull C; Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK., Lam S; BC Cancer Research Institute, University of British Columbia, Vancouver, British Columbia, Canada., Awadalla P; Ontario Institute for Cancer Research, Toronto, Ontario, Canada., Grönroos E; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Downward J; Oncogene Biology Laboratory, The Francis Crick Institute, London, UK., Jacks T; David H. Koch Institute for Integrative Cancer Research, Cambridge, MA, USA.; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA., Carlsten C; Department of Medicine, Division of Respiratory Medicine, Chan-Yeung Centre for Occupational and Environmental Respiratory Disease, Vancouver Coastal Health Research Institute, UBC, Vancouver, British Columbia, Canada., Malanchi I; Tumour-Host Interaction Laboratory, The Francis Crick Institute, London, UK., Hackshaw A; Cancer Research UK and UCL Cancer Trials Centre, London, UK., Litchfield K; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Tumour Immunogenomics and Immunosurveillance Laboratory, University College London Cancer Institute, London, UK., DeGregori J; Department of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Jamal-Hanjani M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK.; Department of Oncology, University College London Hospitals, London, UK., Swanton C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK. Charles.Swanton@crick.ac.uk.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. Charles.Swanton@crick.ac.uk.; Department of Oncology, University College London Hospitals, London, UK. Charles.Swanton@crick.ac.uk.
Publikováno v:
Nature [Nature] 2023 Apr; Vol. 616 (7955), pp. 159-167. Date of Electronic Publication: 2023 Apr 05.